Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression

Xinhua Zou, Wenzhe Fan, Miao Xue, Jiaping Li Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou City, Guangdong Province, 510080, People’s Republic of ChinaCorrespondence: Jiaping LiDepartment of Interventional Oncology, The First Affi...

Full description

Bibliographic Details
Main Authors: Zou X, Fan W, Xue M, Li J
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/evaluation-of-the-benefits-of-tace-combined-with-sorafenib-for-hepatoc-peer-reviewed-fulltext-article-CMAR